Ex vivo tumor testing platform for predicting clinical response to platinum-based therapy in patients with high grade serous ovarian cancer

被引:0
|
作者
Ottevanger, P. B.
Kroep, Judith R.
van Persijn-van Meerten, Els L.
van Altena, Anne M.
de Kroon, Cornelis
Ceton, Lieke J.
Montero, Marta G.
van der Meer, Donny J.
Vader, Willemijn
机构
[1] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands
[4] VitroScan BV, Leiden, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5563
引用
收藏
页数:1
相关论文
共 50 条
  • [41] NOVEL 3D MODEL SYSTEMS TO ASSESS HETEROGENEITY IN RESPONSE TO PLATINUM THERAPY IN HIGH GRADE SEROUS OVARIAN CANCER
    Ploski, Jennifer
    Nixon, Katherine
    Demchenko, Nikita
    Cunnea, Paula
    Fotopoulou, Christina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A99 - A99
  • [42] Habitat Radiomics Based on MRI for Predicting Platinum Resistance in Patients with High-Grade Serous Ovarian Carcinoma: A Multicenter Study
    Bi, Qiu
    Miao, Kun
    Xu, Na
    Hu, Faping
    Yang, Jing
    Shi, Wenwei
    Lei, Ying
    Wu, Yunzhu
    Song, Yang
    Ai, Conghui
    Li, Haiming
    Qiang, Jinwei
    ACADEMIC RADIOLOGY, 2024, 31 (06) : 2367 - 2380
  • [43] Development of ex vivo phenotypic assays to enable precision medicine in the context of high grade serous ovarian cancer
    Nelson, L.
    Tighe, A.
    Clamp, A.
    Edmondson, R.
    Jayson, G.
    Taylor, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S85 - S86
  • [44] Circulating serum miRNAs predict response to platinum chemotherapy in high-grade serous ovarian cancer
    Suzuki, Kazuhiro
    Yokoi, Akira
    Matsuzaki, Juntaro
    Yoshida, Kosuke
    Yamamoto, Yusuke
    Kato, Tomoyasu
    Ishikawa, Mitsuya
    Ochiya, Takahiro
    Kajiyama, Hiroaki
    CANCER MEDICINE, 2024, 13 (22):
  • [45] Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer
    Mise, Branka Petric
    Telesmanic, Vesna Dobric
    Tomic, Snjezana
    Sundov, Dinka
    Capkun, Vesna
    Vrdoljak, Eduard
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (02) : 347 - 356
  • [46] RATES OF GENETIC TESTING IN HIGH GRADE SEROUS OVARIAN CANCER PATIENTS IN THE ERA OF PARP INHIBITOR THERAPY: A POPULATIONBASED STUDY
    Brent, Shannon
    Mcgee, Jacob
    Vicus, Danielle
    Kim, Raymond
    Eisen, Andrea
    Yu, Winnie
    Wilton, Drew
    Gien, Lilian
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A132 - A132
  • [47] COMPREHENSIVE CHARACTERIZATION OF NAIVE TREATMENT SAMPLES OF HIGH GRADE SEROUS OVARIAN CANCER ADDRESSED TO NEOADJUVANT CHEMOTHERAPY: A HYPOTHESIS-GENERATING STUDY ON BIOMARKERS OF RESPONSE TO PLATINUM-BASED CHEMOTHERAPY
    Trozzi, Rita
    Nero, Camilla
    Duranti, Simona
    Giacomini, Flavia
    Marino, Ilenia
    Camarda, Floriana
    Anderson, Gloria
    Pasciuto, Tina
    Giaco, Luciano
    Casu, Paolo
    Giannarelli, Diana
    Fagotti, Anna
    Lorusso, Domenica
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A312 - A313
  • [48] A 2-Protein Signature Predicting Clinical Outcome in High-Grade Serous Ovarian Cancer
    Jin, Chengjuan
    Xue, Yingfeng
    Li, Yingwei
    Bu, Hualei
    Yu, Hongfeng
    Zhang, Tao
    Zhang, Zhiwei
    Yan, Shi
    Lu, Nan
    Kong, Beihua
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (01) : 51 - 58
  • [49] Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
    Xiong, Zhuo
    Ha, Chunfang
    Li, Ruyue
    Wu, Mingyong
    Wei, Meng
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2024, 89 (06) : 469 - 477
  • [50] A CT-based radiomics nomogram for predicting early recurrence in patients with high-grade serous ovarian cancer
    Chen, Hui-zhu
    Wang, Xin-rong
    Zhao, Fu-min
    Chen, Xi-jian
    Li, Xue-sheng
    Ning, Gang
    Guo, Ying-kun
    EUROPEAN JOURNAL OF RADIOLOGY, 2021, 145